RS
IRWD icon

R Squared’s Ironwood Pharmaceuticals IRWD Stock Holding History

R Squared’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38,765
Closed -$27.8K – 629
2025
Q2 		$27.8K Buy
38,765
+28,735
+286% +$22.6K 0.02% 429
2025
Q1 		$14.7K Buy
10,030
+5,040
+101% +$12K 0.02% 283
2024
Q4 		$22.1K Buy
+4,990
New +$20.2K 0.02% 829

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

R Squared's IRWD Position: Q3 2025 in Review

R Squared sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2025, closing a stake of 38,765 shares — an estimated $27.8K sold.

R Squared first reported a position in IRWD in Q4 2024 and held it in 3 quarters. The position peaked at $27.8K in Q2 2025. 166 funds tracked by Wall St. Rank hold IRWD as of Q3 2025.

  • R Squared reported no remaining Ironwood Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • R Squared sold 38,765 Ironwood Pharmaceuticals shares in Q3 2025, an estimated $27.8K.
  • R Squared first reported a position in Ironwood Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • R Squared's Ironwood Pharmaceuticals position peaked at $27.8K in Q2 2025.
  • 166 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2025.

Based on R Squared's 13F filing for Q3 2025, filed 12 Nov 2025.